When.com Web Search

  1. Ads

    related to: nasonex nasal spray boots

Search results

  1. Results From The WOW.Com Content Network
  2. Mometasone - Wikipedia

    en.wikipedia.org/wiki/Mometasone

    Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [10] [11] [12] Specifically it is used to prevent rather than treat asthma attacks. [10]

  3. Nasal spray - Wikipedia

    en.wikipedia.org/wiki/Nasal_spray

    Decongestant nasal sprays are advised for short-term use only, preferably 5 to 7 days at maximum. Some doctors advise to use them 3 days at maximum. A recent clinical trial has shown that a corticosteroid nasal spray may be useful in reversing this condition. [3] Topical nasal decongestants include: Oxymetazoline; Phenylephrine; Xylometazoline

  4. Over 89,000 Bottles of Popular Nasal Spray Recalled By FDA - AOL

    www.aol.com/over-89-000-bottles-popular...

    Nasal spray is being recalled over microbial failure. The U.S. Food and Drug Administration shared information about the recall affecting NeilMed Pharmaceuticals’ NasoGel Spray, last week. Here ...

  5. Nasonex - Wikipedia

    en.wikipedia.org/?title=Nasonex&redirect=no

    From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).

  6. Azelastine - Wikipedia

    en.wikipedia.org/wiki/Azelastine

    Azelastine, sold under the brand name Astelin among others, is a H 1 receptor-blocking medication primarily used as a nasal spray to treat allergic rhinitis (hay fever) and as eye drops for allergic conjunctivitis. [5] [6] Other uses may include asthma and skin rashes for which it is taken by mouth. [7]

  7. FDA-approved nasal spray for severe depression can lead to ...

    www.aol.com/fda-approved-nasal-spray-severe...

    The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.